Showing results (521-530 of 563) with videos related to

Sort By:
Pageof 57
The Lancet. Rheumatology|July 6, 2024
Systemic lupus erythematosus in Aboriginal and Torres Strait Islander peoples in Australia: addressing disparities and barriers to optimising patient careLaura E Eades, Alberta Y Hoi, Ruaidhri Liddle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2020
A Phase I Study of Ruxolitinib, Lenalidomide, and Steroids for Patients with Relapsed/Refractory Multiple MyelomaJames R Berenson, Jennifer To, Tanya M Spektor, et al.
International Journal for Equity in Health|June 25, 2017
Healthcare expenditure on Indigenous and non-Indigenous Australians at high risk of cardiovascular diseaseBlake Angell, Tracey-Lea Laba, Tom Lung, et al.
Experimental Hematology|April 13, 2022
A phase 1/2 study of ixazomib in place of bortezomib or carfilzomib in a subsequent line of therapy for patients with multiple myeloma refractory to their last bortezomib or carfilzomib combination regimenDavid Daniely, Eli Forouzan, Tanya M Spektor, et al.
Blood|November 5, 2015
Targeting CD123 in acute myeloid leukemia using a T-cell-directed dual-affinity retargeting platformMuneera Al-Hussaini, Michael P Rettig, Julie K Ritchey, et al.
European Journal of Haematology|May 16, 2021
Baseline serum B-cell maturation antigen levels predict time to disease progression for patients with smoldering multiple myelomaSean Bujarski, Marissa-Skye Goldwater, Bernard Sean Regidor, et al.
ACS Central Science|December 31, 2025
Depolymerization as a Design Strategy: Depolymerization Etching of Polymerization-Induced Microphase SeparationsKaden C Stevens, Megan E Lott, Kiana A Treaster, et al.
British Journal of Haematology|September 29, 2011
A modified regimen of pegylated liposomal doxorubicin, bortezomib and dexamethasone (DVD) is effective and well tolerated for previously untreated multiple myeloma patientsJames R Berenson, Ori Yellin, Chien-Shing Chen, et al.
Qualitative Health Research|August 8, 2024
A Qualitative Study of Aboriginal Peoples' Health Care Experiences With Chronic Obstructive Pulmonary DiseaseDavid P Meharg, Sarah M Dennis, Justin McNab, et al.
BMC Public Health|August 7, 2010
Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst indigenous and non indigenous people at high cardiovascular riskHueiming Liu, Anushka Patel, Alex Brown, et al.
Pageof 57